Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin

Sharad Ghamande, Shashikant Lele, Bonnie L. Hylander, Ezogelin Oflazoglu, Elizabeth A. Repasky, William Fanslow

Research output: Contribution to journalArticle

86 Scopus citations

Fingerprint Dive into the research topics of 'Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin'. Together they form a unique fingerprint.

Medicine & Life Sciences